Genprex, Inc.

GNPX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 13 employees
241
SEC Filings
$3.5
Close 2026-09-04
13
Employees

Business Summary

Genprex, Inc. is a clinical-stage gene therapy company developing gene-based therapies for cancer and diabetes. Its oncology platform uses the ONCOPREX Delivery System with lipid-based nanoparticles to deliver tumor suppressor genes intravenously. Lead oncology candidate REQORSA (quaratusugene ozeplasmid) is in clinical trials for NSCLC and SCLC. Its diabetes candidate GPX-002 uses an AAV vector containing Pdx1 and MafA genes administered into the pancreatic duct to treat Type 1 and Type 2 diabetes.

Latest Stock Quote

GNPX 2026-09-04 $3.5 O:$3.6 H:$3.6052 L:$3.3873 Vol:0.0M VWAP:$3.5315
origin leaf: null

Next Earnings

expected 2026-11-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001437749-26-010346EDGAR99K words
2025-04-012024-12-310001437749-25-010311EDGAR107K words
2024-04-012023-12-310001437749-24-010426EDGAR87K words
2023-03-312022-12-310001437749-23-008847EDGAR—
2022-03-302021-12-310001437749-22-007680EDGAR—
2021-03-262020-12-310001437749-21-007317EDGAR—
2020-03-302019-12-310001437749-20-006522EDGAR—
2019-04-012018-12-310001564590-19-010279EDGAR—
2018-04-172017-12-310001564590-18-008342EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001437749-26-027846EDGAR27K words
2025-11-142025-09-300001437749-25-035191EDGAR30K words
2025-08-142025-06-300001437749-25-026965EDGAR26K words
2025-05-122025-03-310001437749-25-016133EDGAR22K words
2024-11-132024-09-300001437749-24-034697EDGAR24K words
2024-08-092024-06-300001437749-24-025893EDGAR23K words
2024-05-152024-03-310001437749-24-017061EDGAR20K words
2023-11-142023-09-300001437749-23-031830EDGAR24K words
2023-08-212023-06-300001437749-23-024247EDGAR20K words
2023-05-222023-03-310001437749-23-015445EDGAR17K words
2022-11-142022-09-300001437749-22-027048EDGAR—
2022-08-122022-06-300001437749-22-020379EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-180001437749-26-028250EDGAR1K words
2026-08-050001437749-26-025938EDGAR1K words
2026-08-030001437749-26-025302EDGAR1K words
2026-07-300001437749-26-025074EDGAR2K words
2026-07-140001437749-26-023480EDGAR3K words
2026-03-180001437749-26-008733EDGAR2K words
2026-02-230001437749-26-004954EDGAR1K words
2026-02-100001437749-26-003577EDGAR2K words
2026-01-090001437749-26-000995EDGAR1K words
2026-01-070001437749-26-000694EDGAR2K words

241 total filings indexed. 210 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

non-small-cell-lung-cancer-(nsclc) small-cell-lung-cancer-(sclc) type-1-diabetes type-2-diabetes oncology-gene-therapy diabetes-gene-therapy lipid-based-nanoparticles-(lipoplex-form) adeno-associated-virus-(aav)-vector non-viral-gene-delivery

Company Identity

CIK0001595248
TickerGNPX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedTX
Websitehttps://www.genprex.com
Listed2018-03-29

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 7841c98e6e19a532c98124b9bd2940f2e46904abb23af33abeccce3481a4a1bb
parent: e44c7109552b49939590262aece70b6bda941cc27e2efa8ad2305c248a646479
content hash: 2a99fd521ee67669b5b47ac07d0c22c2a74a5b169295339dd3230ba026a7fca9
signed: 2026-09-28T19:01:29.215Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up GNPX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on GNPX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/GNPX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.